Could a daily eating window shield kidneys in diabetes?

NCT ID NCT06884059

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This trial investigates whether time-restricted eating (TRE) — eating all food within an 8-10 hour window each day — can improve kidney function in people with type 2 diabetes who have elevated protein in their urine (microalbuminuria). All 25 participants follow the same TRE schedule while continuing their usual diabetes care. The study measures changes in urine albumin levels and blood sugar control over the intervention period.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
time-restricted eating (TRE) — consuming all food within an 8-10 hour daily window
What this could lead to
If it works, this could point toward a simple dietary strategy to protect kidney health in people with type 2 diabetes.
What could go wrong
This is a small, early-phase trial with only 25 participants and no control group, so results may not be generalizable. The effect on kidney function may be modest or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MICROALBUMINURIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fasting Intermittent Fasting type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Altman Clinical and Translational Research Institute

    RECRUITING

    La Jolla, California, 92093, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.